This study on the four ALS-causing point mutations in the actin-binding domain of PFN-1 protein reveals the structural deviations in the structure and the possible adverse impact on the PFN-1 interaction and its function. This evidence concerns the gene PFN1 and amyotrophic lateral sclerosis.